Live Breaking News & Updates on Incyte Jakafi Jakavi
Stay updated with breaking news from Incyte jakafi jakavi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Novartis’s €2.7B acquisition of MorphoSys brings two cancer drug candidates, one of which would give the pharmaceutical giant a way to stand apart from other myelofibrosis treatments. In a separate deal, MorphoSys sold to Incyte its rights to a partnered blood cancer drug. ....